Controlling apoptosis: implications for carcinogenesis?
Clarke
A R
AR
Edinburgh University Medical School, Edinburgh, EH8 9AG, UK.
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D004249:DNA Damage; D004260:DNA Repair / Q000235:genetics / Q000502:physiology; D004268:DNA-Binding Proteins / Q000235:genetics / Q000502:physiology; D016158:Genes, p53; D006706:Homeostasis; D006801:Humans; D008957:Models, Genetic; D051718:MutS Homolog 2 Protein; D009369:Neoplasms / Q000235:genetics / Q000473:pathology*; D011518:Proto-Oncogene Proteins / Q000235:genetics / Q000502:physiology; D016159:Tumor Suppressor Protein p53 / Q000502:physiology*
D004268:DNA-Binding Proteins; D011518:Proto-Oncogene Proteins; D016159:Tumor Suppressor Protein p53; C497172:MSH2 protein, human; D051718:MutS Homolog 2 Protein